Vacation was ruined, but local man was first in line for new antibody treatment

By , Daily Memphian Updated: November 17, 2020 8:13 AM CT | Published: November 17, 2020 4:00 AM CT
<strong>Dr. Stephen Threlkeld&rsquo;s practice,&nbsp;Threlkeld Infectious Disease, supervised the infusion of a synthetic antibody into patient Andy Shepherd, who&rsquo;d tested positive for coronavirus. &ldquo;It soups up our response against the virus sooner than we can do ourselves,&rdquo; said Threlkeld. </strong>(Patrick Lantrip/Daily Memphian file)

Dr. Stephen Threlkeld’s practice, Threlkeld Infectious Disease, supervised the infusion of a synthetic antibody into patient Andy Shepherd, who’d tested positive for coronavirus. “It soups up our response against the virus sooner than we can do ourselves,” said Threlkeld. (Patrick Lantrip/Daily Memphian file)

Drug gives a super supply of antibodies, more than the body can make on its own. “I think it’s well worth the small amount of risk it takes,” says Andy Shepherd.

Topics

Andy Shepherd bamlanivimab Eli Lilly and Co Dr. Scott Strome Dr. Stephen Threlkeld Baptist Memorial Health Care
Jane Roberts

Jane Roberts

Jane Roberts has reported in Memphis for more than 20 years. As a senior member of The Daily Memphian staff, she was assigned to the medical beat during the COVID-19 pandemic. She also has done in-depth work on other medical issues facing our community, including shortages of specialists in local hospitals. She covered K-12 education here for years and later the region’s transportation sector, including Memphis International Airport and FedEx Corp.


Comments

Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here